Spyre Therapeutics (SYRE) Return on Capital Employed Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 68,255.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 2,665.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 31,429.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2,503.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -105.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,400.00 |
| 10 | Spyre Therapeutics | 5.55 Bn | 5.55 Bn | - | 1,194.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,194.00 |
| Dec 31, 2025 | 929.00 |
| Sep 30, 2025 | 714.00 |
| Jun 30, 2025 | -950.00 |
| Mar 31, 2025 | 3,159.00 |
| Dec 31, 2024 | 5,462.00 |
| Sep 30, 2024 | 6,733.00 |
| Jun 30, 2024 | -29,188.00 |
| Mar 31, 2024 | 8,805.00 |
| Dec 31, 2023 | 2,723.00 |
| Sep 30, 2023 | -1,375.00 |
| Jun 30, 2023 | 36,714.00 |
| Mar 31, 2023 | -7,142.00 |
| Dec 31, 2022 | -6,103.00 |
| Sep 30, 2022 | -4,784.00 |
| Jun 30, 2022 | -6,192.00 |
| Mar 31, 2022 | -2,764.00 |
| Dec 31, 2021 | -877.00 |
| Sep 30, 2021 | -404.00 |
| Jun 30, 2021 | 3,335.00 |
| Mar 31, 2021 | 8,179.00 |
| Dec 31, 2020 | 5,232.00 |
| Sep 30, 2020 | 2,517.00 |
| Jun 30, 2020 | -2,418.00 |
| Mar 31, 2020 | -8,364.00 |
| Dec 31, 2019 | -3,889.00 |
| Sep 30, 2019 | -2,483.00 |
| Jun 30, 2019 | -248.00 |
| Mar 31, 2019 | 265.00 |
| Dec 31, 2018 | -1,818.00 |
| Sep 30, 2018 | -900.00 |
| Jun 30, 2018 | -1,391.00 |
| Mar 31, 2018 | -2,342.00 |
| Dec 31, 2017 | -1,916.00 |
| Sep 30, 2017 | -1,637.00 |
| Jun 30, 2017 | -870.00 |
| Mar 31, 2017 | 99.00 |